Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
Cellebrite DI Ltd., a foreign private issuer based in Petah Tikva, Israel, filed this Form 6-K on November 12, 2025. The filing serves to distribute a press release announcing the company's financial results for the third quarter of 2025.
Key Financial Metrics
The provided filing text acts as a cover document and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. The filing states that GAAP financial statement tables are incorporated by reference from the attached press release (Exhibit 99.1) and prior registration statements, but the text of those tables is not included in the input.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
This specific filing text contains no management commentary, forward-looking guidance, risk factors, or disclosures of unusual items. Such information is expected to be contained within the referenced press release titled "Cellebrite Announces Third-Quarter 2025 Results."
Key Facts for Investor Verification
- The filing is a procedural Form 6-K dated November 12, 2025, referencing Q3 2025 results.
- Specific financial figures (revenue, net income, cash flow) are not listed in the filing text and must be sourced from Exhibit 99.1.
- The registrant files annual reports on Form 20-F.
- The Chief Financial Officer, David Barter, signed the report on behalf of the registrant.